Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy

Anti-PD-1/PD-L1 therapy has shown significant benefits in the treatment of a variety of malignancies. However, not all cancer patients can benefit from this strategy due to drug resistance. Therefore, there is an urgent need for methods that can effectively improve the efficacy of anti-PD-1/PD-L1 th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junjie, Tao, Haisu, Yuan, Tong, Li, Jiang, Li, Jian, Liang, Huifang, Huang, Zhiyong, Zhang, Erlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479218/
https://www.ncbi.nlm.nih.gov/pubmed/36119072
http://dx.doi.org/10.3389/fimmu.2022.992611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479218/
https://www.ncbi.nlm.nih.gov/pubmed/36119072
http://dx.doi.org/10.3389/fimmu.2022.992611

Ejemplares similares